Cargando…

Association between the metabolome and bone mineral density in a Chinese population

BACKGROUND: Osteoporosis is a common metabolic bone disease, which always leads to osteoporotic fractures. Biomarkers of bone mineral density (BMD) are helpful for prevention and early diagnosis of osteoporosis. This study aims to identify metabolomic biomarkers of low BMD. METHODS: We included 701...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Zhendong, Dong, Xin, Qian, Yu, Hong, Dun, Xie, Ziang, Yao, Guanfeng, Qin, An, Gao, Songyan, Hu, Jianying, Liang, Liming, Zheng, Yan, Su, Jiacan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670189/
https://www.ncbi.nlm.nih.gov/pubmed/33186808
http://dx.doi.org/10.1016/j.ebiom.2020.103111
_version_ 1783610689783332864
author Mei, Zhendong
Dong, Xin
Qian, Yu
Hong, Dun
Xie, Ziang
Yao, Guanfeng
Qin, An
Gao, Songyan
Hu, Jianying
Liang, Liming
Zheng, Yan
Su, Jiacan
author_facet Mei, Zhendong
Dong, Xin
Qian, Yu
Hong, Dun
Xie, Ziang
Yao, Guanfeng
Qin, An
Gao, Songyan
Hu, Jianying
Liang, Liming
Zheng, Yan
Su, Jiacan
author_sort Mei, Zhendong
collection PubMed
description BACKGROUND: Osteoporosis is a common metabolic bone disease, which always leads to osteoporotic fractures. Biomarkers of bone mineral density (BMD) are helpful for prevention and early diagnosis of osteoporosis. This study aims to identify metabolomic biomarkers of low BMD. METHODS: We included 701 participants who had BMD measures by dual-energy X-ray absorptiometry scans and donated fasting plasma samples from three clinical centres as a discovery set and another 278 participants from the fourth centre as an independent replication set. We used a liquid chromatography-mass spectrometry-based metabolomics approach to profile the global metabolites of fasting plasma. FINDINGS: Among the 265 named metabolites identified in our study, six were associated with low BMD (FDR-adjusted P<0.05) in the discovery set and were successfully validated in the independent replication set. The circulating levels of five metabolites, i.e., inosine, hypoxanthine, PC (O-18:0/22:6), SM (d18:1/21:0) and isoleucyl-proline were associated with decreased odds of low BMD, and PC (16:0/18:3) level was associated with increased odds of low BMD. Per 1-SD increase in a composite metabolite score of these six metabolites was associated with about half decreased odds of low BMD (odds ratio 0.59, 95% confidence interval: 0.52-0.68). Furthermore, introduction of a panel of metabolites selected by elastic net regression to a prediction model of classical risk factors and plasma biomarker of bone resorption substantially improved the prediction performance for low BMD (AUCs: 0.782 vs. 0.698, P=0.002). INTERPRETATION: Metabolomics profiling may help identify novel biomarkers of low BMD and be helpful for early diagnosis of osteoporosis beyond the current clinical index. FUNDING: This study was supported by the National Key R&D Program of China [2018YFC2001500 to J.S.], Shanghai Municipal Science and Technology Major Project [2017SHZDZX01], the National Natural Science Foundation of China [Key Program, 91749204 to J.S.], the National Natural Science Foundation of China [General Program, 81771491 to J.S.], the Project of Shanghai Subject Chief Scientist [2017BR011 to J.S.], Grants from the TCM Supported Project [18431902300 to J.S.] from the Science and Technology Commission of Shanghai Municipality, and the National Natural Science Foundation of China [General Program, 81972089 to Z.X.]. Y.Z. was supported by the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, and the National Natural Science Foundation of China [81973032].
format Online
Article
Text
id pubmed-7670189
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-76701892020-11-23 Association between the metabolome and bone mineral density in a Chinese population Mei, Zhendong Dong, Xin Qian, Yu Hong, Dun Xie, Ziang Yao, Guanfeng Qin, An Gao, Songyan Hu, Jianying Liang, Liming Zheng, Yan Su, Jiacan EBioMedicine Research Paper BACKGROUND: Osteoporosis is a common metabolic bone disease, which always leads to osteoporotic fractures. Biomarkers of bone mineral density (BMD) are helpful for prevention and early diagnosis of osteoporosis. This study aims to identify metabolomic biomarkers of low BMD. METHODS: We included 701 participants who had BMD measures by dual-energy X-ray absorptiometry scans and donated fasting plasma samples from three clinical centres as a discovery set and another 278 participants from the fourth centre as an independent replication set. We used a liquid chromatography-mass spectrometry-based metabolomics approach to profile the global metabolites of fasting plasma. FINDINGS: Among the 265 named metabolites identified in our study, six were associated with low BMD (FDR-adjusted P<0.05) in the discovery set and were successfully validated in the independent replication set. The circulating levels of five metabolites, i.e., inosine, hypoxanthine, PC (O-18:0/22:6), SM (d18:1/21:0) and isoleucyl-proline were associated with decreased odds of low BMD, and PC (16:0/18:3) level was associated with increased odds of low BMD. Per 1-SD increase in a composite metabolite score of these six metabolites was associated with about half decreased odds of low BMD (odds ratio 0.59, 95% confidence interval: 0.52-0.68). Furthermore, introduction of a panel of metabolites selected by elastic net regression to a prediction model of classical risk factors and plasma biomarker of bone resorption substantially improved the prediction performance for low BMD (AUCs: 0.782 vs. 0.698, P=0.002). INTERPRETATION: Metabolomics profiling may help identify novel biomarkers of low BMD and be helpful for early diagnosis of osteoporosis beyond the current clinical index. FUNDING: This study was supported by the National Key R&D Program of China [2018YFC2001500 to J.S.], Shanghai Municipal Science and Technology Major Project [2017SHZDZX01], the National Natural Science Foundation of China [Key Program, 91749204 to J.S.], the National Natural Science Foundation of China [General Program, 81771491 to J.S.], the Project of Shanghai Subject Chief Scientist [2017BR011 to J.S.], Grants from the TCM Supported Project [18431902300 to J.S.] from the Science and Technology Commission of Shanghai Municipality, and the National Natural Science Foundation of China [General Program, 81972089 to Z.X.]. Y.Z. was supported by the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, and the National Natural Science Foundation of China [81973032]. Elsevier 2020-11-10 /pmc/articles/PMC7670189/ /pubmed/33186808 http://dx.doi.org/10.1016/j.ebiom.2020.103111 Text en © 2020 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Paper
Mei, Zhendong
Dong, Xin
Qian, Yu
Hong, Dun
Xie, Ziang
Yao, Guanfeng
Qin, An
Gao, Songyan
Hu, Jianying
Liang, Liming
Zheng, Yan
Su, Jiacan
Association between the metabolome and bone mineral density in a Chinese population
title Association between the metabolome and bone mineral density in a Chinese population
title_full Association between the metabolome and bone mineral density in a Chinese population
title_fullStr Association between the metabolome and bone mineral density in a Chinese population
title_full_unstemmed Association between the metabolome and bone mineral density in a Chinese population
title_short Association between the metabolome and bone mineral density in a Chinese population
title_sort association between the metabolome and bone mineral density in a chinese population
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670189/
https://www.ncbi.nlm.nih.gov/pubmed/33186808
http://dx.doi.org/10.1016/j.ebiom.2020.103111
work_keys_str_mv AT meizhendong associationbetweenthemetabolomeandbonemineraldensityinachinesepopulation
AT dongxin associationbetweenthemetabolomeandbonemineraldensityinachinesepopulation
AT qianyu associationbetweenthemetabolomeandbonemineraldensityinachinesepopulation
AT hongdun associationbetweenthemetabolomeandbonemineraldensityinachinesepopulation
AT xieziang associationbetweenthemetabolomeandbonemineraldensityinachinesepopulation
AT yaoguanfeng associationbetweenthemetabolomeandbonemineraldensityinachinesepopulation
AT qinan associationbetweenthemetabolomeandbonemineraldensityinachinesepopulation
AT gaosongyan associationbetweenthemetabolomeandbonemineraldensityinachinesepopulation
AT hujianying associationbetweenthemetabolomeandbonemineraldensityinachinesepopulation
AT liangliming associationbetweenthemetabolomeandbonemineraldensityinachinesepopulation
AT zhengyan associationbetweenthemetabolomeandbonemineraldensityinachinesepopulation
AT sujiacan associationbetweenthemetabolomeandbonemineraldensityinachinesepopulation